Enhancing enhancers: new complexities in the retinoid regulation of gene expression

The Biochemical Journal
Chris P F Redfern

Abstract

Retinoic acid is a signalling molecule central to morphogenesis and musculoskeletal development. It can exist in several isomeric forms, of which all-trans- and 9-cis-retinoic acid are thought to be the most relevant as signalling molecules. Retinoic acid regulates gene expression via RARs (retinoic acid receptors) working as heterodimers with RXRs (retinoid X receptors). RXRs also heterodimerize with other nuclear receptors. In this issue of the Biochemical Journal, Harris et al. have shown that an enhancer responsible for chondrocyte-specific expression of the col11a2 gene is itself regulated by a retinoic-acid-dependent interaction with RXRbeta bound to a downstream response element. Thus, RXRs bound to hormone-response elements can regulate gene expression indirectly via interactions with tissue-specific enhancers. This study raises interesting questions about the nature of the response element, the RXRbeta partner and the ligands able to influence col11a2 expression, and will provide a model system with which to understand tissue and ligand specificity of retinoid responses.

References

Apr 15, 1994·The Biochemical Journal·J Urbach, R R Rando
Dec 15, 1995·Cell·D J Mangelsdorf, R M Evans
Nov 27, 2002·Vascular Pharmacology·Peter A EdwardsPuiying A Mak
Sep 6, 2003·Birth Defects Research. Part C, Embryo Today : Reviews·Andrea D WestonT Michael Underhill
Feb 3, 2004·Journal of Lipid Research·Akira AbeJames A Shayman
Mar 17, 2004·Gene·Julie Bastien, Cécile Rochette-Egly
Jun 23, 2004·The Biochemical Journal·Laura R HarrisLaura C Bridgewater

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.